Evelyn Fahrenkrug
Seminars
Tuesday 9th March 2027
CEO & ADC Pharma Leaders Think Tank: Solidifying Next Generation ADCs as Standard of Care Therapies
9:30 am
- Understanding the 2027 ADC landscape and how the bar has been raised to develop and deliver ADCs with meaningful patient impact
- Outlining the future opportunities and applications on the horizon for ADCs to achieve target differentiation and clinical safety
- Highlighting methods to best pursue ADC clinical differentiation across patient selection technologies, combination strategies, and well-executed clinical design
- With clinical trials advancing in the Far East and Australia, what opportunities does this open for the ADC industry to progress faster?
